{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:47:53Z","timestamp":1793922473558,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bmcl.2024.130070","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T17:22:09Z","timestamp":1734024129000},"page":"130070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Development of 3-indolyl substituted phenyl pyrazolo-carboxamide hybrids as potential type II VEGFR-2 inhibitors and in vitro cytotoxicity studies"],"prefix":"10.1016","volume":"117","author":[{"given":"Durgesh Gurukkala","family":"Valapil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetanjali","family":"Devabattula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman Singh","family":"Barahdia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandraiah","family":"Godugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8733-9431","authenticated-orcid":false,"given":"Nagula","family":"Shankaraiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.130070_b0005","article-title":"Mechanisms of angiogenesis in tumour","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmcl.2024.130070_b0010","article-title":"Biophys. Acta, Rev","volume":"1879","author":"Shaw","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.bmcl.2024.130070_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107278","article-title":"Recent development of VEGFR small molecule inhibitors as anticancer agents: A patent review (2021-2023)","volume":"146","author":"Zeng","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2024.130070_b0020","doi-asserted-by":"crossref","unstructured":"Elgawish MS, Abdeldayem E, Chapter 17 - Vascular endothelial growth factor receptors (VEGFR\/PDGFR) inhibitors, Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy, 2024:443-475, https:\/\/doi.org\/10.1016\/B978-0-323-96121-9.00017-6.","DOI":"10.1016\/B978-0-323-96121-9.00017-6"},{"key":"10.1016\/j.bmcl.2024.130070_b0025","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1039\/D3MD00506B","article-title":"Role of heterocycles in inhibition of VEGFR-2 - a recent update (2019-2022)","volume":"15","author":"Dorababu","year":"2023","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmcl.2024.130070_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116472","article-title":"Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions","volume":"272","author":"Thakur","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.130070_b0035","article-title":"Advances in tumor vascular growth inhibition","author":"Zhang","year":"2024","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.bmcl.2024.130070_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107037","article-title":"Identification of novel ureido benzothiophenes as dual VEGFR-2\/EGFR anticancer agents","volume":"143","author":"Eldehna","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2024.130070_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112457","article-title":"Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect","volume":"200","author":"Sana","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.130070_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106425","article-title":"Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy","volume":"133","author":"Liu","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2024.130070_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Trans Targeted Ther"},{"key":"10.1016\/j.bmcl.2024.130070_b0060","article-title":"New insights on sorafenib resistance in liver cancer with correlation of individualized therapy","volume":"1874","author":"Cheng","year":"2020","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bmcl.2024.130070_b0065","doi-asserted-by":"crossref","unstructured":"A) Mondal D, Amin SA, Moinul M, Das K, Jha T, Gayen S, How the structural properties of the indole derivatives are important in kinase targeted drug design?: A case study on tyrosine kinase inhibitors. Bioorg Med Chem 2022;53:116534. https:\/\/doi.org\/10.1016\/j.bmc.2021.116534.","DOI":"10.1016\/j.bmc.2021.116534"},{"key":"10.1016\/j.bmcl.2024.130070_b0070","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1039\/D3RA08962B","article-title":"Antineoplastic indole-containing compounds with potential VEGFR inhibitory properties","volume":"14","author":"Aboshouk","year":"2024","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmcl.2024.130070_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103470","article-title":"Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line","volume":"97","author":"Bennani","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2024.130070_b0080","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1039\/D2MD00206J","article-title":"Pyrazole-containing pharmaceuticals: target, pharmacological activity, and their SAR studies","volume":"13","author":"Li","year":"2022","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmcl.2024.130070_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000022","article-title":"Structure-activity relationship studies of indolin-2-one derivatives as vascular endothelial growth factor receptor inhibitors and anticancer agents","volume":"353","author":"Yousefian","year":"2020","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmcl.2024.130070_b0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13045-022-01310-7","article-title":"Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy","volume":"15","author":"Liu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.bmcl.2024.130070_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113334","article-title":"Structural insights of oxindole based kinase inhibitors as anticancer agents: Recent advances","volume":"216","author":"Dhokne","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.130070_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106313","article-title":"Synthesis and cytotoxicity evaluation of DNA-interactive \u03b2-carboline indolyl-3-glyoxamide derivatives: Topo-II inhibition and in silico modelling studies","volume":"131","author":"Soni","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2024.130070_b0105","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1039\/D2MD00442A","article-title":"Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors","volume":"14","author":"Soni","year":"2023","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmcl.2024.130070_b0110","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1039\/D2CY01441F","article-title":"Chemo- and Regio-Selective Amidation of Indoles with Isocyanates Using Borane Lewis Acids","volume":"12","author":"Dasgupta","year":"2022","journal-title":"Cat Sci Technol"},{"key":"10.1016\/j.bmcl.2024.130070_b0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"Cell sensitivity assays: the MTT assay","volume":"731","author":"Van Meerloo","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bmcl.2024.130070_b0120","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/adt.2009.0222","article-title":"ADP-Glo: A Bioluminescent and homogeneous ADP monitoring assay for kinases","volume":"7","author":"Zegzouti","year":"2009","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.bmcl.2024.130070_b0125","doi-asserted-by":"crossref","unstructured":"a) Kasibhatla S, Amarante-Mendes GP, Finucane D, Brunner T, Bossy-Wetzel E, Green DR, Acridine orange\/ethidium bromide (AO\/EB) staining to detect apoptosis., Cold Spring Harb. Protoc. 2006;3:pdb. prot4493. https:\/\/doi.org\/10.1101\/pdb.prot4493, b)Tokala, R., Sana, S., Lakshmi, U.J., Sankarana, P., Sigalapalli, D.K., Gadewal, N., Kode, J. and Shankaraiah, N, Design and synthesis of thiadiazolo-carboxamide bridged \u03b2-carboline-indole hybrids: DNA intercalative topo-II\u03b1 inhibition with promising antiproliferative activity.Bioorg. Chem., 2020. 105, p.104357.https:\/\/doi.org\/10.1016\/j.bioorg.2020.104357.","DOI":"10.1016\/j.bioorg.2020.104357"},{"key":"10.1016\/j.bmcl.2024.130070_b0130","doi-asserted-by":"crossref","unstructured":"Chazotte B, Labeling nuclear DNA using DAPI, Cold Spring Harbor Protoc. 2011;1:pdb.prot5556. https:\/\/doi.org\/10.1101\/pdb.prot5556.","DOI":"10.1101\/pdb.prot5556"},{"key":"10.1016\/j.bmcl.2024.130070_b0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-60761-411-1_4","article-title":"Identification of ROS using oxidized DCFDA and flow-cytometry","volume":"594","author":"Eruslanov","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bmcl.2024.130070_b0140","first-page":"23","article-title":"Wound-healing assay","volume":"294","author":"Rodriguez","year":"2005","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bmcl.2024.130070_b0145","article-title":"Novel VEGFR-2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies","volume":"20","author":"Vishakha","year":"2023","journal-title":"ChemBiodiversity"},{"key":"10.1016\/j.bmcl.2024.130070_b0150","unstructured":"Desmond Molecular Dynamics System, version 3.5, D.E. Shaw Research, New York, NY, 2013. Maestro-Desmond Interoperability Tools, version 3.5, Schr\u00f6dinger, New York, NY, 2013."},{"key":"10.1016\/j.bmcl.2024.130070_b0155","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2174\/15680266113139990033","article-title":"In silico ADMET prediction: recent advances, current challenges and future trends","volume":"13","author":"Cheng","year":"2013","journal-title":"Curr Top Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24004724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24004724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T21:24:08Z","timestamp":1737321848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X24004724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":31,"alternative-id":["S0960894X24004724"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.130070","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of 3-indolyl substituted phenyl pyrazolo-carboxamide hybrids as potential type II VEGFR-2 inhibitors and in vitro cytotoxicity studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.130070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130070"}}